HIF1A and diabetes mellitus: Patients with diabetes have decreased bone regeneration capacity and cells cultured in hyperglycaemic conditions (25 and 50 mM) have been demonstrated to have an impaired HIF-1α pathway and a consequent reduced ability to respond to hypoxic conditions39.